{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:37:39Z","timestamp":1787683059943,"version":"build-2784847793"},"reference-count":41,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2025,10,31]]},"DOI":"10.5582\/bst.2025.01244","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T22:07:45Z","timestamp":1756159665000},"page":"484-494","source":"Crossref","is-referenced-by-count":3,"title":["Chinese expert consensus on the combined use of antiviral drugs for novel coronavirus infection"],"prefix":"10.5582","volume":"19","author":[{"given":"Guangbin","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Third People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Third People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wei","sequence":"additional","affiliation":[{"name":"Guangdong Medical University, Dongguan Campus, Dongguan, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfen","family":"Wu","sequence":"additional","affiliation":[{"name":"Shenzhen Hospital of Beijing University of Chinese Medicine (Longgang) Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Center for Infectious Disease Research, The Third People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Third People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, The Third People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Liver Disease center, Beijing You&apos;an Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yourou","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhen","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Third People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Infection and Immunology, Shanghai Public Health Clinical Center, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Chong","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hainan Public Health Clinical Center, Haikou, Hainan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuojiong","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilong","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Guangzhou Eighth People&apos;s Hospital, Guangzhou Medical University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, Yunnan Infectious Diseases Hospital, Kunming, Yunnan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghui","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Bao&apos;an District People&apos;s Hospital, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Longgang Central Hospital of Shenzhen, Shenzhen, Guangdong,China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hainan General Hospital, Haikou, Hainan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingliang","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuguo","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, the first Dongguan affiliated Hospital of Guangdong Medical University, Dongguan, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsha","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shenshan Hospital, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Third People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuqing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Third People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxin","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Longgang Central Hospital, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Third People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Third People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Shenzhen Hospital of Traditional Chinese Medicine, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shunde Hospital, Jinan University, Foshan, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third People&apos;s Hospital of Longgang District, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Qian","sequence":"additional","affiliation":[{"name":"Ethics Office, The Second People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongfang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shunde Hospital of Shunde District, Foshan, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HaiLin","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Zhongshan Torch Development Zone People&apos;s Hospital, Zhongshan, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yantian People&apos;s Hospital, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Hu","sequence":"additional","affiliation":[{"name":"Liver Disease center, Beijing You&apos;an Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhou","family":"Lu","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Infectious Diseases, Division of Infectious Diseases, The Third People&apos;s Hospital of Shenzhen, Shenzhen, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"National Medical Research Center for Infectious Diseases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gao Y, Zhang J, Liu M, <i>et al<\/i>. Superior antiviral efficacy of combined 3CL protease and RdRp inhibition compared to 3CL protease inhibitor monotherapy in hospitalized COVID-19 patients. J Infect. 2025; 90:106502.","DOI":"10.1016\/j.jinf.2025.106502"},{"key":"2","unstructured":"2. General Office of the National Health Commission, General Department of the National Adiministration of Traditional Chinese Medicine. Diagnosis and treatment protocol for COVID-19 (Trial version 10). [2023-01-07] <i>https:\/\/www.gov.cn\/zhengce\/zhengceku\/2023-01\/06\/content_5735343.htm<\/i>. (accessed August 12, 2025). (in Chinese)"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chen GB, Zheng YR, Yu YN, Liang LM, Chao C, Liu YX, Lu HZ. Concomitant and sequential administration of nirmatrelvir-ritonavir and azvudine in patients with COVID-19 caused by the Omicron variant: Safety and efficacy. iLABMED. 2024; 2: 88-97.","DOI":"10.1002\/ila2.40"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Asakawa T, Cai Q, Shen J, <i>et al<\/i>. Sequelae of long COVID, known and unknown: A review of updated information. Biosci Trends. 2023; 17:85-116.","DOI":"10.5582\/bst.2023.01039"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Li Q, Zheng XS, Shen XR, <i>et al<\/i>. Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19. Emerg Microbes Infect. 2020; 9:2571-2577.","DOI":"10.1080\/22221751.2020.1852058"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Alizon S, Sofonea MT. SARS-CoV-2 epidemiology, kinetics, and evolution: A narrative review. Virulence. 2025; 16:2480633.","DOI":"10.1080\/21505594.2025.2480633"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Sch\u00fcnemann HJ. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011; 64:383-394.","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hollstein MM, Dierks S, Sch\u00f6n MP, <i>et al<\/i>. Humoral and cellular immune responses in fully vaccinated individuals with or without SARS-CoV-2 breakthrough infection: results from the CoV-ADAPT cohort. J Med Virol. 2023; 95:e29122.","DOI":"10.1002\/jmv.29122"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Primorac D, Vrdoljak K, Brlek P, Paveli\u0107 E, Molnar V, Mati\u0161i\u0107 V, Erceg Ivko\u0161i\u0107 I, Par\u010dina M. Adaptive Immune Responses and Immunity to SARS-CoV-2. Front Immunol. 2022; 13:848582.","DOI":"10.3389\/fimmu.2022.848582"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Salleh MZ, Derrick JP, Deris ZZ. Structural evaluation of the spike glycoprotein variants on SARS-CoV-2 transmission and immune evasion. Int J Mol Sci. 2021; 22:7425.","DOI":"10.3390\/ijms22147425"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Udoakang AJ, Djomkam Zune AL, Tapela K, Nganyewo NN, Olisaka FN, Anyigba CA, Tawiah-Eshun S, Owusu IA, Paemka L, Awandare GA, Quashie PK. The COVID-19, tuberculosis and HIV\/AIDS: M\u00e9nage \u00e0 trois. Front Immunol. 2023; 14:1104828.","DOI":"10.3389\/fimmu.2023.1104828"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tamura TJ, Choudhary MC, Deo R, <i>et al<\/i>. Emerging SARS-CoV-2 resistance after antiviral treatment. JAMA Netw Open. 2024; 7:e2435431.","DOI":"10.1001\/jamanetworkopen.2024.35431"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chen L, Zody MC, Di Germanio C, <i>et al<\/i>. Emergence of multiple SARS-CoV-2 antibody escape variants in an immunocompromised host undergoing convalescent plasma treatment. mSphere. 2021; 6:e0048021.","DOI":"10.1128\/mSphere.00480-21"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Maruki T, Nomoto H, Iwamoto N, Yamamoto K, Kurokawa M, Iwatsuki-Horimoto K, Yamayoshi S, Suzuki Y, Kawaoka Y, Ohmagari N. Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir\/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma. J Infect Chemother. 2024; 30:793-795.","DOI":"10.1016\/j.jiac.2024.01.008"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Longo BM, Venuti F, Gaviraghi A, Lupia T, Ranzani FA, Pepe A, Ponzetta L, Vita D, Allice T, Gregorc V, Frascione PMM, De Rosa FG, Calcagno A, Bonora S. Sequential or combination treatments as rescue therapies in immunocompromised patients with persistent SARS-CoV-2 infection in the omicron era: A case series. Antibiotics (Basel). 2023; 12:1460.","DOI":"10.3390\/antibiotics12091460"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Baldi F, Dentone C, Mikulska M, <i>et al<\/i>. Case report: sotrovimab, remdesivir and nirmatrelvir\/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19. Front Med (Lausanne). 2023; 9:1062450.","DOI":"10.3389\/fmed.2022.1062450"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Marangoni D, Antonello RM, Coppi M, Palazzo M, Nassi L, Streva N, Povolo L, Malentacchi F, Zammarchi L, Rossolini GM, Vannucchi AM, Bartoloni A, Spinicci M. Combination regimen of nirmatrelvir\/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: A case report and a scoping review of the literature. Int J Infect Dis. 2023; 133:53-56.","DOI":"10.1016\/j.ijid.2023.04.412"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Trottier CA, Wong B, Kohli R, Boomsma C, Magro F, Kher S, Anderlind C, Golan Y. Dual antiviral therapy for persistent coronavirus disease 2019 and associated organizing pneumonia in an immunocompromised host. Clin Infect Dis. 2023; 76:923-925.","DOI":"10.1093\/cid\/ciac847"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wagoner J, Herring S, Hsiang TY, Ianevski A, Biering SB, Xu S, Hoffmann M, P\u00f6hlmann S, Gale M Jr, Aittokallio T, Schiffer JT, White JM, Polyak SJ. Combinations of host- and virus-targeting antiviral drugs confer synergistic suppression of SARS-CoV-2. Microbiol Spectr. 2022; 10:e0333122.","DOI":"10.1128\/spectrum.03331-22"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Zhou S, Long N, Rosenke K, Jarvis MA, Feldmann H, Swanstrom R. Combined treatment of severe acute respiratory syndrome coronavirus 2 reduces molnupiravir-induced mutagenicity and prevents selection for nirmatrelvir\/ritonavir resistance Mutations. J Infect Dis. 2024; 230:1380-1383","DOI":"10.1093\/infdis\/jiae213"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rosenke K, Lewis MC, Feldmann F, Bohrnsen E, Schwarz B, Okumura A, Bohler WF, Callison J, Shaia C, Bosio CM, Lovaglio J, Saturday G, Jarvis MA, Feldmann H. Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaques. JCI Insight. 2023; 8:e166485.","DOI":"10.1172\/jci.insight.166485"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Corey L, Beyrer C, Cohen MS, Michael NL, Bedford T, Rolland M. SARS-CoV-2 variants in patients with immunosuppression. N Engl J Med. 2021; 385:562-566.","DOI":"10.1056\/NEJMsb2104756"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kemp SA, Collier DA, Datir RP, <i>et al<\/i>. SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021; 592: 277-282.","DOI":"10.1038\/s41586-021-03291-y"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Jeong JH, Chokkakula S, Min SC, Kim BK, Choi WS, Oh S, Yun YS, Kang DH, Lee OJ, Kim EG, Choi JH, Lee JY, Choi YK, Baek YH, Song MS. Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice. Antiviral Res. 2022; 208:105430.","DOI":"10.1016\/j.antiviral.2022.105430"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Gidari A, Sabbatini S, Schiaroli E, Bastianelli S, Pierucci S, Busti C, Comez L, Libera V, Macchiarulo A, Paciaroni A, Vicenti I, Zazzi M, Francisci D. The combination of molnupiravir with nirmatrelvir or GC376 has a synergic role in the inhibition of SARS-CoV-2 replication <i>in vitro<\/i>. Microorganisms. 2022; 10:1475.","DOI":"10.3390\/microorganisms10071475"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Phan T, Ribeiro RM, Edelstein GE, <i>et al<\/i>. Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance. J Virol. 2025; 99:e0162324.","DOI":"10.1128\/jvi.01623-24"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hirsch C, Kreuzberger N, Skoetz N, Monsef I, Kluge S, Spinner CD, Malin JJ. Efficacy and safety of antiviral therapies for the treatment of persistent COVID-19 in immunocompromised patients since the Omicron surge: A systematic review. J Antimicrob Chemother. 2025; 80:633-644.","DOI":"10.1093\/jac\/dkae482"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Antonel lo RM, Marangoni D, Ducci F, <i>et al<\/i>. Antiviral combination regimens as rescue therapy in immunocompromised hosts with persistent COVID-19. J Chemother. 2025; 37:130-134.","DOI":"10.1080\/1120009X.2024.2367935"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Shokrollahi Barough M, Darzi M, Yunesian M, <i>et al<\/i>. Retrospective analysis of COVID-19 clinical and laboratory data: Constructing a multivariable model across different comorbidities. J Infect Public Health. 2024; 17:102566.","DOI":"10.1016\/j.jiph.2024.102566"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Gao YD, Ding M, Dong X, <i>et al<\/i>. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021; 76:428-455.","DOI":"10.1111\/all.14657"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Gentile I, Foggia M, Silvitelli M, Sardanelli A, Cattaneo L, Viceconte G. Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir\/ritonavir and sotrovimab. Virol J. 2023; 20:301.","DOI":"10.1186\/s12985-023-02269-8"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Trapani S, Masiero L, Puoti F, <i>et al<\/i>. Incidence and outcome of SARS-CoV-2 infection on solid organ transplantation recipients: A nationwide population-based study. Am J Transplant. 2021; 21:2509-2521.","DOI":"10.1111\/ajt.16428"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Alhuneafat L, Khalid MU, Jabri A, Deicke MD, Virk S, Jacobs MW, Hsich E, Alqarqaz M, Dunlap ME, Kassis-George H, Link C. Early pandemic in-hospital outcomes and mortality risk factors in COVID-19 solid organ transplant patients. Proc (Bayl Univ Med Cent). 2024; 37:414-423.","DOI":"10.1080\/08998280.2024.2325310"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Vinson AJ, Agarwal G, Dai R, Anzalone AJ, Lee SB, French E, Olex A, Madhira V, Mannon RB. COVID-19 in solid organ transplantation: Results of the National COVID Cohort Collaborative. Transplant Direct. 2021; 7:e775.","DOI":"10.1097\/TXD.0000000000001234"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Pannu V, Udongwo N, Imburgio S, Johal A, Mararenko A, Pozdniakova H, Amin T, Patel S, Hossain M, Mushtaq A, Liu E, Fune JM, Heaton J. Adverse events of SARS-CoV-2 therapy: A pharmacovigilance study of the FAERS database. Ann Pharmacother. 2024; 58:105-109.","DOI":"10.1177\/10600280231169256"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Liang Y, Ma L, Wang Y, Zheng J, Su L, Lyu J. Adverse events associated with molnupiravir: A real-world disproportionality analysis in Food and Drug Administration adverse event reporting system. Front Pharmacol. 2023; 14:1253799.","DOI":"10.3389\/fphar.2023.1253799"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Atmar RL, Finch N. New perspectives on antimicrobial agents: Molnupiravir and nirmatrelvir\/ritonavir for treatment of COVID-19. Agents Chemother. 2022; 66:e0240421.","DOI":"10.1128\/aac.02404-21"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Saravolatz LD, Depcinski S, Sharma M. Molnupiravir and nirmatrelvir-ritonavir: Oral coronavirus disease 2019 antiviral drugs. Clin Infect Dis. 2023; 76:165-171.","DOI":"10.1093\/cid\/ciac180"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Jafari M, Pormohammad A, Sheikh Neshin SA, Ghorbani S, Bose D, Alimohammadi S, Basirjafari S, Mohammadi M, Rasmussen-Ivey C, Razizadeh MH, Nouri-Vaskeh M, Zarei M. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis. Rev Med Virol. 2021; 31:1-16.","DOI":"10.1002\/rmv.2208"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Stock SJ, Carruthers J, Calvert C, <i>et al<\/i>. SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland [published correction appears in Nat Med. 2022; 28:599]. Nat Med. 2022; 28:504-512.","DOI":"10.1038\/s41591-021-01666-2"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Hassan O, Elbhairy AA, Siam AM, Abdelwahab T, Hamad AA, Mahmoud OE, Nabeh OA. Evaluating the safety and efficacy of nirmatrelvir-ritonavir therapy in pregnant women with COVID-19: A systematic review and meta-analysis. Eur J Clin Pharmacol. 2025; 81:495-506.","DOI":"10.1007\/s00228-025-03808-8"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/19\/5\/19_2025.01244\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T04:03:39Z","timestamp":1763179419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/19\/5\/19_2025.01244\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2025.01244","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"2025.01244"}}